Is Cowden syndrome hereditary?

TL;DR: Cowden syndrome is a hereditary condition caused by germline mutations in the PTEN gene, which are inherited in an autosomal dominant pattern. This means an affected parent has a 50% chance of passing the genetic mutation to each of their children, though new (de novo) mutations also occur in individuals with no family history.

Is Cowden syndrome genetic or hereditary?

Cowden syndrome is both a genetic and a hereditary condition. "Genetic" refers to the fact that the disease is caused by a change (mutation) in a person's DNA, specifically within the PTEN tumor suppressor gene. "Hereditary" means that this mutation can be passed down from parents to their children through the germline. Because Cowden syndrome is caused by a change in a single gene, it is classified as a monogenic disorder, which distinguishes it from multifactorial conditions where many genes and environmental factors interact.

What is the inheritance pattern of Cowden syndrome?

Cowden syndrome follows an autosomal dominant inheritance pattern. In this context, "autosomal" means the PTEN gene is located on one of the non-sex chromosomes, and "dominant" means that only one copy of the mutated gene—inherited from either the mother or the father—is sufficient to cause the syndrome. While many individuals inherit Cowden syndrome from an affected parent, a significant portion of cases are the result of de novo mutations. These are spontaneous genetic changes that occur for the first time in the affected individual, meaning neither parent carries the mutation.

How is genetic testing and counseling utilized?

Genetic testing for Cowden syndrome is highly recommended for individuals who meet clinical diagnostic criteria, such as the presence of multiple hamartomatous tumors, macrocephaly, or a personal/family history of specific cancers like breast, thyroid, or endometrial cancer. Clinical geneticists use molecular testing to identify pathogenic variants in the PTEN gene. For families, the following points are critical regarding clinical management:

• 50% Risk: Each child of an individual with Cowden syndrome has a 50% statistical probability of inheriting the PTEN mutation.


• Genetic Counseling: Pre-test and post-test counseling are essential to discuss the implications of a positive result, including lifelong cancer surveillance protocols.


• Cascade Testing: Once a mutation is identified in a family, "cascade testing" is offered to at-risk relatives to determine if they also carry the mutation and require increased medical screening.


• Reproductive Options: Families planning pregnancies may explore options such as preimplantation genetic testing (PGT) to screen embryos for the PTEN mutation before implantation.

Do all people with a PTEN mutation develop the same symptoms?

It is important to note that Cowden syndrome exhibits variable expressivity. This means that even within the same family, individuals with the exact same PTEN mutation may experience vastly different symptoms or degrees of disease severity. Some individuals may have very mild physical features, while others may have a higher predisposition to the characteristic cancers associated with the condition. As of today, 116 people with Cowden syndrome have shared their personal experiences within the DiseaseMaps.org community, highlighting the diverse ways this genetic condition presents in daily life.

Next steps

• Consult with a board-certified clinical geneticist to discuss your family history and the appropriateness of PTEN gene testing.


• Request a referral to a high-risk cancer genetics clinic to establish a personalized surveillance plan if you test positive for Cowden syndrome.


• Connect with the DiseaseMaps.org community to learn from the experiences of others living with this rare condition.


• Review updated clinical guidelines from the National Comprehensive Cancer Network (NCCN) regarding the management of PTEN hamartoma tumor syndrome.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases (GARD) Information Center: PTEN hamartoma tumor syndrome.


• Orphanet: Cowden syndrome (ORPHA:207).


• Online Mendelian Inheritance in Man (OMIM): PTEN-Hamartoma Tumor Syndrome (Entry #158350).


• NCCN Guidelines: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic.